Company Filing History:
Years Active: 2002
Title: Innovator in Pharmaceutical Development: Ping-Hui Tseng
Introduction: Ping-Hui Tseng, based in Wur, Taiwan, is a dedicated inventor known for his contributions to the field of drug development. With a profound focus on liver disease, he has made significant strides through his innovative research and patented methodologies.
Latest Patents: Tseng holds a patent for an "Anti liver disease drug R-YEEE and method of synthesizing branched galactose-terminal glycoproteins." This groundbreaking invention provides a novel method for synthesizing branched galactose-terminal glycoproteins, which exhibit binding affinity to the asialoglycoprotein receptor. Furthermore, this patent outlines the creation of conjugates that combine these glycoproteins with therapeutically effective agents, including isolated proteins, polysaccharides, lipids, and radioactive isotopes. Such conjugates are designed to effectively deliver therapeutically beneficial agents to mammalian cells, with a specific focus on hepatocytes.
Career Highlights: Ping-Hui Tseng is associated with Academia Sinica, a prominent research institution that plays a vital role in advancing scientific knowledge and technology. His dedication to research has earned him recognition and respect in the academic community.
Collaborations: Throughout his career, Tseng has collaborated with esteemed colleagues, including Shui-Tein Chen and Weir-Torn Jiaang. These partnerships underscore the importance of teamwork in driving innovation and achieving significant breakthroughs in the field of pharmaceuticals.
Conclusion: Ping-Hui Tseng's contributions to the development of anti-liver disease drugs and methodologies represent a notable advancement in therapeutic options. His work not only showcases his innovative spirit but also contributes to the broader efforts to combat liver diseases, highlighting the critical role of inventors in the medical field.